Open AccessIn vitro susceptibilities of Aeromonas hydrophila against new antibiotics
Author(s) -
Victor Fainstein,
Susanne Weaver,
Gerald P. Bodey
Publication year - 1982
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.22.3.513
Subject(s) - moxalactam , ceftizoxime , cefotaxime , cefoperazone , aeromonas hydrophila , microbiology and biotechnology , antibiotics , aeromonas , cephalosporin , trimethoprim , tetracycline , penicillin , sulfamethoxazole , chemistry , biology , antibiotic resistance , bacteria , imipenem , genetics
The antibiotic susceptibilities of 16 clinical isolates of Aeromonas hydrophila obtained from cancer patients with septicemia were studied. Of the new beta-lactam antibiotics tested, azthreonam and moxalactam were the most active, followed by cefoperazone, cefotaxime, and ceftizoxime. Excellent activity was demonstrated by chloroamphenicol, tetracycline, aminoglycosides, and trimethoprim-sulfamethoxazole. Semisynthetic penicillins had no appreciable activity against this organism.